{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:35:57Z","timestamp":1767983757238,"version":"3.49.0"},"reference-count":47,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,9,24]],"date-time":"2008-09-24T00:00:00Z","timestamp":1222214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurochemistry"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We have previously demonstrated that adenosine controls the release of catecholamines (CA) from carotid body (CB) acting on A<jats:sub>2B<\/jats:sub>receptors. Here, we have tested the hypothesis that the control is exerted via an interaction between adenosine A<jats:sub>2B<\/jats:sub>and dopamine D<jats:sub>2<\/jats:sub>receptors present in chemoreceptor cells. Experiments were performed<jats:italic>in vitro<\/jats:italic>in CB from 3\u2003months rats. The effect of A<jats:sub>2B<\/jats:sub>adenosine and D<jats:sub>2<\/jats:sub>dopamine agonists and antagonists applied alone or in combination were studied on basal (20%O<jats:sub>2<\/jats:sub>) and hypoxia (10%O<jats:sub>2<\/jats:sub>)\u2010evoked release of CA and cAMP content of CB. We have found that adenosine A<jats:sub>2<\/jats:sub>agonists and D<jats:sub>2<\/jats:sub>antagonists dose\u2010dependently increased basal and evoked release CA from the CB while A<jats:sub>2<\/jats:sub>antagonists and D<jats:sub>2<\/jats:sub>agonists had an inhibitory action. The existence of A<jats:sub>2B<\/jats:sub>\u2010D<jats:sub>2<\/jats:sub>receptor interaction was established because the inhibitory action of A<jats:sub>2<\/jats:sub>antagonists was abolished by D<jats:sub>2<\/jats:sub>antagonists, and the stimulatory action of A<jats:sub>2<\/jats:sub>agonists was abolished by D<jats:sub>2<\/jats:sub>agonists. Further, A<jats:sub>2<\/jats:sub>agonists increased and D<jats:sub>2<\/jats:sub>agonist decreased cAMP content in the CB; their co\u2010application eliminated the response. The present results provide direct pharmacological evidence that an antagonistic interaction between A<jats:sub>2B<\/jats:sub>adenosine and D<jats:sub>2<\/jats:sub>dopamine receptors exist in rat CB and would explain the dopamine\u2010adenosine interactions on ventilation previously observed.<\/jats:p>","DOI":"10.1111\/j.1471-4159.2008.05704.x","type":"journal-article","created":{"date-parts":[[2008,9,24]],"date-time":"2008-09-24T15:01:04Z","timestamp":1222268464000},"page":"1369-1381","source":"Crossref","is-referenced-by-count":43,"title":["An antagonistic interaction between A<sub>2B<\/sub>adenosine and D<sub>2<\/sub>dopamine receptors modulates the function of rat carotid body chemoreceptor cells"],"prefix":"10.1111","volume":"107","author":[{"given":"Silvia V.","family":"Conde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constancio","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana R.","family":"Batuca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia C.","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Obeso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,11,11]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1986.sp016254"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(91)90315-K"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1997.272.2.C628"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1076\/apab.105.1.3.13145"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-9280-2_48"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2004.02380.x"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2006.03912.x"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(81)90056-2"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-2236(97)01096-5"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2007.07.001"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1982.sp014439"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1982.sp014441"},{"key":"e_1_2_7_14_1","first-page":"1319","volume-title":"The Lung: Scientific Foundations","author":"Fidone S. J.","year":"1991"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4402132"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(00)00570-0"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-006-0589-0"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/jemt.10190"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(00)02314-3"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1994.74.4.829"},{"key":"e_1_2_7_21_1","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0022-3565(24)35231-0","article-title":"R(+)\u20108\u2010OH\u2010DPAT, a serotonin(1A) receptor agonist, potentiated S(\u2010)\u2010sulpiride\u2010induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum","volume":"291","author":"Ichikawa J.","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresrev.2004.05.007"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(02)00067-2"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.2000.279.2.L273"},{"key":"e_1_2_7_25_1","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0022-3565(24)38019-X","article-title":"Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens","volume":"288","author":"Kuroki T.","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2005.11.040"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1981.tb09964.x"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1983.tb10040.x"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00177715"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00168974"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/0-306-46825-5_66"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-5891-0_45"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2003.tb00239.x"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2004.03.015"},{"key":"e_1_2_7_35_1","first-page":"179","volume-title":"Physiology and Pharmacology of Adenosine Derivatives","author":"Ribeiro J. A.","year":"1983"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/07328319108047232"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(90)90504-3"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6989(95)00037-Z"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2005.05.013"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2000.00214.x"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.2000.278.3.C490"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-1375-9_8"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1985.tb05108.x"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2004.10.007"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00546.2005"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(01)00069-7"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1042\/CS20070018"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7793.2003.00825.x"}],"container-title":["Journal of Neurochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-4159.2008.05704.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-4159.2008.05704.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T02:13:07Z","timestamp":1738375987000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-4159.2008.05704.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,11]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["10.1111\/j.1471-4159.2008.05704.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05704.x","archive":["Portico"],"relation":{},"ISSN":["0022-3042","1471-4159"],"issn-type":[{"value":"0022-3042","type":"print"},{"value":"1471-4159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,11]]}}}